journal article·2026-03-25

Air Discharge Plasma-Activated Hydrosols with Phased RONS-Mediated Anti-Infection, Anti-Inflammation, and Tissue Remodeling Effects for the Integrated Treatment of Chronic Wounds

Hao Zhang, Xixi Jing, Zewei Wang, Tong Wu, Chengbiao Ding, Dingxin Liu, Jishen Zhang, Yuan Zhao, Li Guo, Yumin Xia, Mingzhe Rong, Qian Liu, Yin Xiao, Xiaolin Zhang, Paul K. Chu

ACS Applied Materials & Interfaces· Volume 18· Issue 11
Publisher page

Abstract

Chronic wound repair requires strategies integrating anti-infection, anti-inflammation, and tissue regeneration across wound healing stages. Nevertheless, few therapeutic approaches can incorporate all of these strategies. Although cold atmospheric plasma can regulate cell physiology and pathology through the generation of reactive oxygen and nitrogen species (RONS) and is promising in wound healing applications, how to store and deliver optimal RONS to chronic wound sites is highly challenging. Herein, the air discharge plasma-activated sodium alginate hydrosol (PAH SA ) is used to carry RONS to accomplish integrated chronic wound treatment. In vitro results demonstrate that abundant aqueous RONS are incorporated into PAH SA by gas–liquid reactions between the plasma and sodium alginate hydrosol. PAH SA, boasting promising RONS storage and slow-release properties, shows phased RONS-mediated sterilization, macrophage polarization regulation, and cell migration. Moreover, in the animal model with chronic wound healing, PAH SA reduces bacterial infection through a controlled local inflammatory reaction and promotes growth factor release to stimulate tissue regeneration. Continuous delivery of RONS with gradient concentrations is biocompatible and shows no systemic toxicity. This study demonstrates that the natural decay of plasma-generated RONS can be temporally matched to the dynamic needs of the healing process, underscoring the clinical potential of plasma-activated hydrosols in integrated chronic wound treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Plasma Applications and Diagnostics · Wound Healing and Treatments · Surface Modification and Superhydrophobicity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine

Xi’an Jiaotong University

Department of Physics, Department of Materials Science and Engineering, and Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong 999077, China

Frontier Institute of Science and Technology

Interdisciplinary Research Center of Frontier science and technology

Department of Dermatology

The Second Affiliated Hospital of Xi’an Jiaotong University

Hoffmann Institute of Advanced Materials, Shenzhen Polytechnic University, 7098 Liuxian Boulevard, Shenzhen 518055, China

School of Medicine and Dentistry & Institute for Biomedicine and Glycomics

Griffith University

Funding

National Natural Science Foundation of China (NSFC) · Guangdong ? Hong Kong Technology Cooperation Funding Scheme · Fundamental Research Funds for the Central University, City University of Hong Kong Donation Research Grants

References (40)

Show source-provided references
1. 10.1016/j.jaad.2015.08.07010.1016/j.jaad.2015.08.070 ↗
2. 10.1590/abd1806-4841.2016474110.1590/abd1806-4841.20164741 ↗
3. 10.1002/exp.2025044310.1002/exp.20250443 ↗
4. 10.1016/j.mtchem.2022.10131910.1016/j.mtchem.2022.101319 ↗
5. Zhang T. · J. Biomed. Eng. · 2019 · 36 · 1055
6. 10.1002/exp.2023017610.1002/exp.20230176 ↗
7. 10.1016/j.redox.2021.10211610.1016/j.redox.2021.102116 ↗
8. 10.1016/j.procbio.2021.11.01710.1016/j.procbio.2021.11.017 ↗
9. 10.1109/trpms.2025.360587510.1109/trpms.2025.3605875 ↗
10. 10.4103/mgr.MEDGASRES-D-24-0004310.4103/mgr.MEDGASRES-D-24-00043 ↗
11. 10.1002/ppap.20130007010.1002/ppap.201300070 ↗
12. 10.1099/jmm.0.020263-010.1099/jmm.0.020263-0 ↗
13. 10.1016/j.physrep.2016.03.00310.1016/j.physrep.2016.03.003 ↗
14. 10.1111/iwj.1255710.1111/iwj.12557 ↗
15. 10.1002/adhm.20180121010.1002/adhm.201801210 ↗
16. 10.1088/1361-6463/ac939810.1088/1361-6463/ac9398 ↗
17. 10.3390/microorganisms807109110.3390/microorganisms8071091 ↗
18. 10.1021/acsami.4c1400610.1021/acsami.4c14006 ↗
19. 10.1002/advs.20220740710.1002/advs.202207407 ↗
20. 10.1002/adhm.7066310.1002/adhm.70663 ↗
21. 10.1016/j.biomaterials.2021.12105710.1016/j.biomaterials.2021.121057 ↗
22. 10.1088/1361-6463/ae08c510.1088/1361-6463/ae08c5 ↗
23. 10.1016/j.ijbiomac.2023.12545410.1016/j.ijbiomac.2023.125454 ↗
24. 10.1021/acsami.5c1268510.1021/acsami.5c12685 ↗
25. 10.1021/acsami.4c2086710.1021/acsami.4c20867 ↗
26. 10.1016/j.tibtech.2024.07.01310.1016/j.tibtech.2024.07.013 ↗
27. 10.1063/5.006985110.1063/5.0069851 ↗
28. 10.1088/2058-6272/ac248210.1088/2058-6272/ac2482 ↗
29. 10.1088/1361-7246595/ac60c010.1088/1361-7246595/ac60c0 ↗
30. 10.1002/advs.20220125410.1002/advs.202201254 ↗
31. 10.1016/j.intimp.2025.11435210.1016/j.intimp.2025.114352 ↗
32. 10.1089/ars.2009.260110.1089/ars.2009.2601 ↗
33. 10.1038/s41420-025-02775-410.1038/s41420-025-02775-4 ↗
34. 10.1089/wound.2012.038110.1089/wound.2012.0381 ↗
35. 10.1111/j.1742-481X.2012.01097.x10.1111/j.1742-481X.2012.01097.x ↗
36. 10.1016/j.bioactmat.2020.12.00610.1016/j.bioactmat.2020.12.006 ↗
37. 10.1063/1.487850510.1063/1.4878505 ↗
38. 10.1088/1361-6463/acd0bb10.1088/1361-6463/acd0bb ↗
39. 10.1088/1361-6463/ac61b110.1088/1361-6463/ac61b1 ↗
40. 10.1002/advs.20220740710.1002/advs.202207407 ↗